Moderna 2022 J.P. Morgan Healthcare Conference Presentation

Moderna's presentation at the 40th Annual J.P. Morgan Healthcare Conference in January 2022 covers the company's COVID-19 vaccine portfolio, including variant-specific and booster candidates, as well as its broader pipeline of mRNA-based vaccines against CMV, RSV, Zika, HIV, and personalized cancer vaccines. The presentation outlines manufacturing expansion plans across Canada, Africa, and Australia, and discusses capital allocation priorities including reinvestment, acceleration, and shareholder returns.